Advanced search
Publication Cover
Modern Rheumatology Volume 26, 2016 - Issue 3
Journal homepage
198
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis

Hideaki YamakawaDepartment of Respiratory Medicine, Jikei University School of Medicine, Kashiwa Hospital, Chiba, JapanCorrespondence[email protected]
,
Masahiro YoshidaDepartment of Respiratory Medicine, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
,
Hiroaki KatagiDepartment of Diagnostic Pathology, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
,
Shinichi HirookaDepartment of Diagnostic Pathology, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
,
Keitaro OkudaDepartment of Respiratory Medicine, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
,
Takeo IshikawaDepartment of Respiratory Medicine, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
,
Masamichi TakagiDepartment of Respiratory Medicine, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan
&
Kazuyoshi KuwanoDivision of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
 show all
Pages 441-444 | Received 17 Jan 2014, Accepted 25 Feb 2014, Published online: 01 Apr 2014

References

  • Agarwal SK. Core management principles in rheumatoid arthritis to help guide managed care professionals. J Manag Care Pharm. 2011;17(9 Suppl B):S03–8.
  • Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum. 2007;56(5):1433–9.
  • Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34(2):322–31.
  • Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14(6):1943–9.
  • Gaulard P, Swerdlow SH, Harris NL, Jaffe ES, Sundstrom C. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. Tumours of Haematopoietic and Lymphoid Tissues. Pathology & Genetics. World Health Organization Classification of Tumours. 4th ed. Lyon: IARC Press; 2008. pp. 350–1.
  • Harris NL, Swerdlow SH. Methotrexate-associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of Haematopoietic and Lymphoid Tissues. Pathology & Genetics. World Health Organization Classification of Tumours. 3rd ed. Lyon: IARC Press; 2001. pp. 270–1.
  • Kojima M, Itoh H, Hirabayashi K, Igarashi S, Tamaki Y, Murayama K, et al. Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol Res Pract. 2006;202(9):679–85.
  • Georgescu L, Paget SA. Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?Drug Saf. 1999;20(6):475–87.
  • Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004;104(1):243–9.
  • Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer. 2000;88(3):497–502.
  • Hatanaka K, Nakamura N, Kojima M, Ando K, Irie S, Bunno M, et al. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract. 2010;206(1):9–13.
  • Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91(1):20–8.
  • Pipitone N, Vaglio A, Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol. 2012;26(4):439–48.
  • Moseley AC, Lindsley HB, Skikne BS, Tawfik O. Reversible methotorexate associated lymphoproliferative disease evolving into Hodgkin's disease. J Rheumatol. 2000;27(3):810–3.
  • Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241–51.
  • Rosenkrantz AB, Spieler B, Seuss CR, Stifelman MD, Kim S. Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma. AJR Am J Roentgenol. 2012;199(1): 118–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.